Otsuka Holdings
4578.T
#746
Rank
C$43.46 B
Marketcap
C$82.29
Share price
0.13%
Change (1 day)
3.32%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: C$1.44 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are C$14.47 Billion. In 2023 the company made an earning of C$1.44 Billion a decrease over its 2022 earnings that were of C$1.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023C$1.44 B-20.93%
2022C$1.83 B-12.7%
2021C$2.09 B-19.92%
2020C$2.61 B13.9%
2019C$2.29 B52.07%
2018C$1.51 B11.22%
2017C$1.35 B-36.03%
2016C$2.12 B31.15%
2015C$1.62 B
2013C$3.36 B33.52%
2012C$2.51 B-4.65%
2011C$2.64 B45.53%
2010C$1.81 B